Drug safety evaluation of intravitreal triamcinolone acetonide

By Veritti Daniele   Di Giulio Andrea   Sarao Valentina   Lanzetta Paolo  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 331-340

Informa Healthcare

Access to resources Recommend Favorite

Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 149-172

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

By Ciulla Thomas A   Harris Alon   McIntyre Nathaniel   Jonescu-Cuypers Christian  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 953-959

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema

By Yilmaz Taygan   Cordero-Coma Miguel   Federici Thomas J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1327-1335

Informa Healthcare

Access to resources Recommend Favorite

Enhanced permeation of triamcinolone acetonide through the buccal mucosa

By Shin S.-C.   Kim J.-Y.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 217-220

Elsevier

Access to resources Recommend Favorite